A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects

NCT03168984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Japanese and Caucasian Subjects

Interventions

DRUG: UCB0942
OTHER: Placebo

Sponsor

UCB Biopharma S.P.R.L.